Table of Content

1 Cellular and Gene Therapy Product Market Overview
1.1 Product Overview and Scope of Cellular and Gene Therapy Product
1.2 Cellular and Gene Therapy Product Segment by Type
1.2.1 Global Cellular and Gene Therapy Product Market Value Comparison by Type (2023-2033)
1.2.2 Cellular Immunotherapies
1.2.3 Cancer Vaccines
1.2.4 Autologous and Allogeneic Cells
1.3 Cellular and Gene Therapy Product Segment by Application
1.3.1 Global Cellular and Gene Therapy Product Market Value by Application: (2023-2033)
1.3.2 Blood Cancer
1.3.3 Prostate Cancer
1.3.4 Skin Cancer
1.3.5 Other
1.4 Global Cellular and Gene Therapy Product Market Size Estimates and Forecasts
1.4.1 Global Cellular and Gene Therapy Product Revenue 2018-2033
1.4.2 Global Cellular and Gene Therapy Product Sales 2018-2033
1.4.3 Global Cellular and Gene Therapy Product Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 Cellular and Gene Therapy Product Market Competition by Manufacturers
2.1 Global Cellular and Gene Therapy Product Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cellular and Gene Therapy Product Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cellular and Gene Therapy Product Average Price by Manufacturers (2018-2023)
2.4 Global Cellular and Gene Therapy Product Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cellular and Gene Therapy Product, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cellular and Gene Therapy Product, Product Type & Application
2.7 Cellular and Gene Therapy Product Market Competitive Situation and Trends
2.7.1 Cellular and Gene Therapy Product Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cellular and Gene Therapy Product Players Market Share by Revenue
2.7.3 Global Cellular and Gene Therapy Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cellular and Gene Therapy Product Retrospective Market Scenario by Region
3.1 Global Cellular and Gene Therapy Product Market Size by Region: 2018 Versus 2022 Versus 2033
3.2 Global Cellular and Gene Therapy Product Global Cellular and Gene Therapy Product Sales by Region: 2018-2033
3.2.1 Global Cellular and Gene Therapy Product Sales by Region: 2018-2023
3.2.2 Global Cellular and Gene Therapy Product Sales by Region: 2024-2033
3.3 Global Cellular and Gene Therapy Product Global Cellular and Gene Therapy Product Revenue by Region: 2018-2033
3.3.1 Global Cellular and Gene Therapy Product Revenue by Region: 2018-2023
3.3.2 Global Cellular and Gene Therapy Product Revenue by Region: 2024-2033
3.4 North America Cellular and Gene Therapy Product Market Facts & Figures by Country
3.4.1 North America Cellular and Gene Therapy Product Market Size by Country: 2018 VS 2022 VS 2033
3.4.2 North America Cellular and Gene Therapy Product Sales by Country (2018-2033)
3.4.3 North America Cellular and Gene Therapy Product Revenue by Country (2018-2033)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cellular and Gene Therapy Product Market Facts & Figures by Country
3.5.1 Europe Cellular and Gene Therapy Product Market Size by Country: 2018 VS 2022 VS 2033
3.5.2 Europe Cellular and Gene Therapy Product Sales by Country (2018-2033)
3.5.3 Europe Cellular and Gene Therapy Product Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cellular and Gene Therapy Product Market Facts & Figures by Country
3.6.1 Asia Pacific Cellular and Gene Therapy Product Market Size by Country: 2018 VS 2022 VS 2033
3.6.2 Asia Pacific Cellular and Gene Therapy Product Sales by Country (2018-2033)
3.6.3 Asia Pacific Cellular and Gene Therapy Product Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cellular and Gene Therapy Product Market Facts & Figures by Country
3.7.1 Latin America Cellular and Gene Therapy Product Market Size by Country: 2018 VS 2022 VS 2033
3.7.2 Latin America Cellular and Gene Therapy Product Sales by Country (2018-2033)
3.7.3 Latin America Cellular and Gene Therapy Product Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cellular and Gene Therapy Product Market Facts & Figures by Country
3.8.1 Middle East and Africa Cellular and Gene Therapy Product Market Size by Country: 2018 VS 2022 VS 2033
3.8.2 Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2018-2033)
3.8.3 Middle East and Africa Cellular and Gene Therapy Product Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cellular and Gene Therapy Product Sales by Type (2018-2033)
4.1.1 Global Cellular and Gene Therapy Product Sales by Type (2018-2023)
4.1.2 Global Cellular and Gene Therapy Product Sales by Type (2024-2033)
4.1.3 Global Cellular and Gene Therapy Product Sales Market Share by Type (2018-2033)
4.2 Global Cellular and Gene Therapy Product Revenue by Type (2018-2033)
4.2.1 Global Cellular and Gene Therapy Product Revenue by Type (2018-2023)
4.2.2 Global Cellular and Gene Therapy Product Revenue by Type (2024-2033)
4.2.3 Global Cellular and Gene Therapy Product Revenue Market Share by Type (2018-2033)
4.3 Global Cellular and Gene Therapy Product Price by Type (2018-2033)
5 Segment by Application
5.1 Global Cellular and Gene Therapy Product Sales by Application (2018-2033)
5.1.1 Global Cellular and Gene Therapy Product Sales by Application (2018-2023)
5.1.2 Global Cellular and Gene Therapy Product Sales by Application (2024-2033)
5.1.3 Global Cellular and Gene Therapy Product Sales Market Share by Application (2018-2033)
5.2 Global Cellular and Gene Therapy Product Revenue by Application (2018-2033)
5.2.1 Global Cellular and Gene Therapy Product Revenue by Application (2018-2023)
5.2.2 Global Cellular and Gene Therapy Product Revenue by Application (2024-2033)
5.2.3 Global Cellular and Gene Therapy Product Revenue Market Share by Application (2018-2033)
5.3 Global Cellular and Gene Therapy Product Price by Application (2018-2033)
6 Key Companies Profiled
6.1 Bristol-Myers Squibb
6.1.1 Bristol-Myers Squibb Corporation Information
6.1.2 Bristol-Myers Squibb Description and Business Overview
6.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Product Portfolio
6.1.5 Bristol-Myers Squibb Recent Developments/Updates
6.2 New York Blood Center
6.2.1 New York Blood Center Corporation Information
6.2.2 New York Blood Center Description and Business Overview
6.2.3 New York Blood Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.2.4 New York Blood Center Cellular and Gene Therapy Product Product Portfolio
6.2.5 New York Blood Center Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson & Johnson Cellular and Gene Therapy Product Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Cleveland Cord Blood Center
6.4.1 Cleveland Cord Blood Center Corporation Information
6.4.2 Cleveland Cord Blood Center Description and Business Overview
6.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Product Portfolio
6.4.5 Cleveland Cord Blood Center Recent Developments/Updates
6.5 Organogenesis
6.5.1 Organogenesis Corporation Information
6.5.2 Organogenesis Description and Business Overview
6.5.3 Organogenesis Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Organogenesis Cellular and Gene Therapy Product Product Portfolio
6.5.5 Organogenesis Recent Developments/Updates
6.6 Duke University School of Medicine
6.6.1 Duke University School of Medicine Corporation Information
6.6.2 Duke University School of Medicine Description and Business Overview
6.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Product Portfolio
6.6.5 Duke University School of Medicine Recent Developments/Updates
6.7 Colorado Cord Blood Banking
6.6.1 Colorado Cord Blood Banking Corporation Information
6.6.2 Colorado Cord Blood Banking Description and Business Overview
6.6.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Product Portfolio
6.7.5 Colorado Cord Blood Banking Recent Developments/Updates
6.8 MD Anderson Cancer Center
6.8.1 MD Anderson Cancer Center Corporation Information
6.8.2 MD Anderson Cancer Center Description and Business Overview
6.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Product Portfolio
6.8.5 MD Anderson Cancer Center Recent Developments/Updates
6.9 LifeSouth Community Blood Centers
6.9.1 LifeSouth Community Blood Centers Corporation Information
6.9.2 LifeSouth Community Blood Centers Description and Business Overview
6.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product Portfolio
6.9.5 LifeSouth Community Blood Centers Recent Developments/Updates
6.10 Bloodworks Northwest
6.10.1 Bloodworks Northwest Corporation Information
6.10.2 Bloodworks Northwest Description and Business Overview
6.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Product Portfolio
6.10.5 Bloodworks Northwest Recent Developments/Updates
6.11 Amgen
6.11.1 Amgen Corporation Information
6.11.2 Amgen Cellular and Gene Therapy Product Description and Business Overview
6.11.3 Amgen Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Amgen Cellular and Gene Therapy Product Product Portfolio
6.11.5 Amgen Recent Developments/Updates
6.12 Novartis Pharmaceuticals
6.12.1 Novartis Pharmaceuticals Corporation Information
6.12.2 Novartis Pharmaceuticals Cellular and Gene Therapy Product Description and Business Overview
6.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Product Portfolio
6.12.5 Novartis Pharmaceuticals Recent Developments/Updates
6.13 Castle Creek Biosciences
6.13.1 Castle Creek Biosciences Corporation Information
6.13.2 Castle Creek Biosciences Cellular and Gene Therapy Product Description and Business Overview
6.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Product Portfolio
6.13.5 Castle Creek Biosciences Recent Developments/Updates
6.14 Spark Therapeutics
6.14.1 Spark Therapeutics Corporation Information
6.14.2 Spark Therapeutics Cellular and Gene Therapy Product Description and Business Overview
6.14.3 Spark Therapeutics Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Spark Therapeutics Cellular and Gene Therapy Product Product Portfolio
6.14.5 Spark Therapeutics Recent Developments/Updates
6.15 Vericel
6.15.1 Vericel Corporation Information
6.15.2 Vericel Cellular and Gene Therapy Product Description and Business Overview
6.15.3 Vericel Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Vericel Cellular and Gene Therapy Product Product Portfolio
6.15.5 Vericel Recent Developments/Updates
6.16 Dendreon Pharmaceuticals
6.16.1 Dendreon Pharmaceuticals Corporation Information
6.16.2 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Description and Business Overview
6.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product Portfolio
6.16.5 Dendreon Pharmaceuticals Recent Developments/Updates
6.17 Enzyvant Therapeutics GmbH
6.17.1 Enzyvant Therapeutics GmbH Corporation Information
6.17.2 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Description and Business Overview
6.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product Portfolio
6.17.5 Enzyvant Therapeutics GmbH Recent Developments/Updates
6.18 Mallinckrodt
6.18.1 Mallinckrodt Corporation Information
6.18.2 Mallinckrodt Cellular and Gene Therapy Product Description and Business Overview
6.18.3 Mallinckrodt Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Mallinckrodt Cellular and Gene Therapy Product Product Portfolio
6.18.5 Mallinckrodt Recent Developments/Updates
6.19 Gilead Sciences
6.19.1 Gilead Sciences Corporation Information
6.19.2 Gilead Sciences Cellular and Gene Therapy Product Description and Business Overview
6.19.3 Gilead Sciences Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Gilead Sciences Cellular and Gene Therapy Product Product Portfolio
6.19.5 Gilead Sciences Recent Developments/Updates
6.20 bluebird bio
6.20.1 bluebird bio Corporation Information
6.20.2 bluebird bio Cellular and Gene Therapy Product Description and Business Overview
6.20.3 bluebird bio Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
6.20.4 bluebird bio Cellular and Gene Therapy Product Product Portfolio
6.20.5 bluebird bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cellular and Gene Therapy Product Industry Chain Analysis
7.2 Cellular and Gene Therapy Product Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cellular and Gene Therapy Product Production Mode & Process
7.4 Cellular and Gene Therapy Product Sales and Marketing
7.4.1 Cellular and Gene Therapy Product Sales Channels
7.4.2 Cellular and Gene Therapy Product Distributors
7.5 Cellular and Gene Therapy Product Customers
8 Cellular and Gene Therapy Product Market Dynamics
8.1 Cellular and Gene Therapy Product Industry Trends
8.2 Cellular and Gene Therapy Product Market Drivers
8.3 Cellular and Gene Therapy Product Market Challenges
8.4 Cellular and Gene Therapy Product Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Cellular and Gene Therapy Product Market Value Comparison by Type (2023-2033) & (US$ Million)
Table 2. Global Cellular and Gene Therapy Product Market Value Comparison by Application (2023-2033) & (US$ Million)
Table 3. Global Cellular and Gene Therapy Product Market Competitive Situation by Manufacturers in 2022
Table 4. Global Cellular and Gene Therapy Product Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Cellular and Gene Therapy Product Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Cellular and Gene Therapy Product Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Cellular and Gene Therapy Product Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Cellular and Gene Therapy Product, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Cellular and Gene Therapy Product, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cellular and Gene Therapy Product, Product Type & Application
Table 12. Global Key Manufacturers of Cellular and Gene Therapy Product, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cellular and Gene Therapy Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cellular and Gene Therapy Product as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cellular and Gene Therapy Product Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 17. Global Cellular and Gene Therapy Product Sales by Region (2018-2023) & (K Units)
Table 18. Global Cellular and Gene Therapy Product Sales Market Share by Region (2018-2023)
Table 19. Global Cellular and Gene Therapy Product Sales by Region (2024-2033) & (K Units)
Table 20. Global Cellular and Gene Therapy Product Sales Market Share by Region (2024-2033)
Table 21. Global Cellular and Gene Therapy Product Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Cellular and Gene Therapy Product Revenue Market Share by Region (2018-2023)
Table 23. Global Cellular and Gene Therapy Product Revenue by Region (2024-2033) & (US$ Million)
Table 24. Global Cellular and Gene Therapy Product Revenue Market Share by Region (2024-2033)
Table 25. North America Cellular and Gene Therapy Product Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 26. North America Cellular and Gene Therapy Product Sales by Country (2018-2023) & (K Units)
Table 27. North America Cellular and Gene Therapy Product Sales by Country (2024-2033) & (K Units)
Table 28. North America Cellular and Gene Therapy Product Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Cellular and Gene Therapy Product Revenue by Country (2024-2033) & (US$ Million)
Table 30. Europe Cellular and Gene Therapy Product Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 31. Europe Cellular and Gene Therapy Product Sales by Country (2018-2023) & (K Units)
Table 32. Europe Cellular and Gene Therapy Product Sales by Country (2024-2033) & (K Units)
Table 33. Europe Cellular and Gene Therapy Product Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Cellular and Gene Therapy Product Revenue by Country (2024-2033) & (US$ Million)
Table 35. Asia Pacific Cellular and Gene Therapy Product Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 36. Asia Pacific Cellular and Gene Therapy Product Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Cellular and Gene Therapy Product Sales by Region (2024-2033) & (K Units)
Table 38. Asia Pacific Cellular and Gene Therapy Product Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Cellular and Gene Therapy Product Revenue by Region (2024-2033) & (US$ Million)
Table 40. Latin America Cellular and Gene Therapy Product Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 41. Latin America Cellular and Gene Therapy Product Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Cellular and Gene Therapy Product Sales by Country (2024-2033) & (K Units)
Table 43. Latin America Cellular and Gene Therapy Product Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Cellular and Gene Therapy Product Revenue by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Cellular and Gene Therapy Product Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 46. Middle East & Africa Cellular and Gene Therapy Product Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Cellular and Gene Therapy Product Sales by Country (2024-2033) & (K Units)
Table 48. Middle East & Africa Cellular and Gene Therapy Product Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Cellular and Gene Therapy Product Revenue by Country (2024-2033) & (US$ Million)
Table 50. Global Cellular and Gene Therapy Product Sales (K Units) by Type (2018-2023)
Table 51. Global Cellular and Gene Therapy Product Sales (K Units) by Type (2024-2033)
Table 52. Global Cellular and Gene Therapy Product Sales Market Share by Type (2018-2023)
Table 53. Global Cellular and Gene Therapy Product Sales Market Share by Type (2024-2033)
Table 54. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Type (2024-2033)
Table 56. Global Cellular and Gene Therapy Product Revenue Market Share by Type (2018-2023)
Table 57. Global Cellular and Gene Therapy Product Revenue Market Share by Type (2024-2033)
Table 58. Global Cellular and Gene Therapy Product Price (US$/Unit) by Type (2018-2023)
Table 59. Global Cellular and Gene Therapy Product Price (US$/Unit) by Type (2024-2033)
Table 60. Global Cellular and Gene Therapy Product Sales (K Units) by Application (2018-2023)
Table 61. Global Cellular and Gene Therapy Product Sales (K Units) by Application (2024-2033)
Table 62. Global Cellular and Gene Therapy Product Sales Market Share by Application (2018-2023)
Table 63. Global Cellular and Gene Therapy Product Sales Market Share by Application (2024-2033)
Table 64. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Cellular and Gene Therapy Product Revenue (US$ Million) by Application (2024-2033)
Table 66. Global Cellular and Gene Therapy Product Revenue Market Share by Application (2018-2023)
Table 67. Global Cellular and Gene Therapy Product Revenue Market Share by Application (2024-2033)
Table 68. Global Cellular and Gene Therapy Product Price (US$/Unit) by Application (2018-2023)
Table 69. Global Cellular and Gene Therapy Product Price (US$/Unit) by Application (2024-2033)
Table 70. Bristol-Myers Squibb Corporation Information
Table 71. Bristol-Myers Squibb Description and Business Overview
Table 72. Bristol-Myers Squibb Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Bristol-Myers Squibb Cellular and Gene Therapy Product Product
Table 74. Bristol-Myers Squibb Recent Developments/Updates
Table 75. New York Blood Center Corporation Information
Table 76. New York Blood Center Description and Business Overview
Table 77. New York Blood Center Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. New York Blood Center Cellular and Gene Therapy Product Product
Table 79. New York Blood Center Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Johnson & Johnson Cellular and Gene Therapy Product Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Cleveland Cord Blood Center Corporation Information
Table 86. Cleveland Cord Blood Center Description and Business Overview
Table 87. Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product
Table 89. Cleveland Cord Blood Center Recent Developments/Updates
Table 90. Organogenesis Corporation Information
Table 91. Organogenesis Description and Business Overview
Table 92. Organogenesis Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Organogenesis Cellular and Gene Therapy Product Product
Table 94. Organogenesis Recent Developments/Updates
Table 95. Duke University School of Medicine Corporation Information
Table 96. Duke University School of Medicine Description and Business Overview
Table 97. Duke University School of Medicine Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Duke University School of Medicine Cellular and Gene Therapy Product Product
Table 99. Duke University School of Medicine Recent Developments/Updates
Table 100. Colorado Cord Blood Banking Corporation Information
Table 101. Colorado Cord Blood Banking Description and Business Overview
Table 102. Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product
Table 104. Colorado Cord Blood Banking Recent Developments/Updates
Table 105. MD Anderson Cancer Center Corporation Information
Table 106. MD Anderson Cancer Center Description and Business Overview
Table 107. MD Anderson Cancer Center Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. MD Anderson Cancer Center Cellular and Gene Therapy Product Product
Table 109. MD Anderson Cancer Center Recent Developments/Updates
Table 110. LifeSouth Community Blood Centers Corporation Information
Table 111. LifeSouth Community Blood Centers Description and Business Overview
Table 112. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product
Table 114. LifeSouth Community Blood Centers Recent Developments/Updates
Table 115. Bloodworks Northwest Corporation Information
Table 116. Bloodworks Northwest Description and Business Overview
Table 117. Bloodworks Northwest Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Bloodworks Northwest Cellular and Gene Therapy Product Product
Table 119. Bloodworks Northwest Recent Developments/Updates
Table 120. Amgen Corporation Information
Table 121. Amgen Description and Business Overview
Table 122. Amgen Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Amgen Cellular and Gene Therapy Product Product
Table 124. Amgen Recent Developments/Updates
Table 125. Novartis Pharmaceuticals Corporation Information
Table 126. Novartis Pharmaceuticals Description and Business Overview
Table 127. Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product
Table 129. Novartis Pharmaceuticals Recent Developments/Updates
Table 130. Castle Creek Biosciences Corporation Information
Table 131. Castle Creek Biosciences Description and Business Overview
Table 132. Castle Creek Biosciences Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Castle Creek Biosciences Cellular and Gene Therapy Product Product
Table 134. Castle Creek Biosciences Recent Developments/Updates
Table 135. Spark Therapeutics Corporation Information
Table 136. Spark Therapeutics Description and Business Overview
Table 137. Spark Therapeutics Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Spark Therapeutics Cellular and Gene Therapy Product Product
Table 139. Spark Therapeutics Recent Developments/Updates
Table 140. Vericel Corporation Information
Table 141. Vericel Description and Business Overview
Table 142. Vericel Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Vericel Cellular and Gene Therapy Product Product
Table 144. Vericel Recent Developments/Updates
Table 145. Dendreon Pharmaceuticals Corporation Information
Table 146. Dendreon Pharmaceuticals Description and Business Overview
Table 147. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product
Table 149. Dendreon Pharmaceuticals Recent Developments/Updates
Table 150. Enzyvant Therapeutics GmbH Corporation Information
Table 151. Enzyvant Therapeutics GmbH Description and Business Overview
Table 152. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product
Table 154. Enzyvant Therapeutics GmbH Recent Developments/Updates
Table 155. Mallinckrodt Corporation Information
Table 156. Mallinckrodt Description and Business Overview
Table 157. Mallinckrodt Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Mallinckrodt Cellular and Gene Therapy Product Product
Table 159. Mallinckrodt Recent Developments/Updates
Table 160. Gilead Sciences Corporation Information
Table 161. Gilead Sciences Description and Business Overview
Table 162. Gilead Sciences Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Gilead Sciences Cellular and Gene Therapy Product Product
Table 164. Gilead Sciences Recent Developments/Updates
Table 165. bluebird bio Corporation Information
Table 166. bluebird bio Description and Business Overview
Table 167. bluebird bio Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. bluebird bio Cellular and Gene Therapy Product Product
Table 169. bluebird bio Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Cellular and Gene Therapy Product Distributors List
Table 173. Cellular and Gene Therapy Product Customers List
Table 174. Cellular and Gene Therapy Product Market Trends
Table 175. Cellular and Gene Therapy Product Market Drivers
Table 176. Cellular and Gene Therapy Product Market Challenges
Table 177. Cellular and Gene Therapy Product Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cellular and Gene Therapy Product
Figure 2. Global Cellular and Gene Therapy Product Market Value Comparison by Type (2023-2033) & (US$ Million)
Figure 3. Global Cellular and Gene Therapy Product Market Share by Type in 2022 & 2033
Figure 4. Cellular Immunotherapies Product Picture
Figure 5. Cancer Vaccines Product Picture
Figure 6. Autologous and Allogeneic Cells Product Picture
Figure 7. Global Cellular and Gene Therapy Product Market Value Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Cellular and Gene Therapy Product Market Share by Application in 2022 & 2033
Figure 9. Blood Cancer
Figure 10. Prostate Cancer
Figure 11. Skin Cancer
Figure 12. Other
Figure 13. Global Cellular and Gene Therapy Product Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Cellular and Gene Therapy Product Market Size (2018-2033) & (US$ Million)
Figure 15. Global Cellular and Gene Therapy Product Sales (2018-2033) & (K Units)
Figure 16. Global Cellular and Gene Therapy Product Average Price (US$/Unit) & (2018-2033)
Figure 17. Cellular and Gene Therapy Product Report Years Considered
Figure 18. Cellular and Gene Therapy Product Sales Share by Manufacturers in 2022
Figure 19. Global Cellular and Gene Therapy Product Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Cellular and Gene Therapy Product Players: Market Share by Revenue in 2022
Figure 21. Cellular and Gene Therapy Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Cellular and Gene Therapy Product Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Figure 23. North America Cellular and Gene Therapy Product Sales Market Share by Country (2018-2033)
Figure 24. North America Cellular and Gene Therapy Product Revenue Market Share by Country (2018-2033)
Figure 25. United States Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 26. Canada Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 27. Europe Cellular and Gene Therapy Product Sales Market Share by Country (2018-2033)
Figure 28. Europe Cellular and Gene Therapy Product Revenue Market Share by Country (2018-2033)
Figure 29. Germany Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 30. France Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 31. U.K. Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 32. Italy Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 33. Russia Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 34. Asia Pacific Cellular and Gene Therapy Product Sales Market Share by Region (2018-2033)
Figure 35. Asia Pacific Cellular and Gene Therapy Product Revenue Market Share by Region (2018-2033)
Figure 36. China Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 37. Japan Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 38. South Korea Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 39. India Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 40. Australia Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Taiwan Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 42. Indonesia Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 43. Thailand Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 44. Malaysia Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 45. Latin America Cellular and Gene Therapy Product Sales Market Share by Country (2018-2033)
Figure 46. Latin America Cellular and Gene Therapy Product Revenue Market Share by Country (2018-2033)
Figure 47. Mexico Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 48. Brazil Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 49. Argentina Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Cellular and Gene Therapy Product Sales Market Share by Country (2018-2033)
Figure 51. Middle East & Africa Cellular and Gene Therapy Product Revenue Market Share by Country (2018-2033)
Figure 52. Turkey Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 54. UAE Cellular and Gene Therapy Product Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 55. Global Sales Market Share of Cellular and Gene Therapy Product by Type (2018-2033)
Figure 56. Global Revenue Market Share of Cellular and Gene Therapy Product by Type (2018-2033)
Figure 57. Global Cellular and Gene Therapy Product Price (US$/Unit) by Type (2018-2033)
Figure 58. Global Sales Market Share of Cellular and Gene Therapy Product by Application (2018-2033)
Figure 59. Global Revenue Market Share of Cellular and Gene Therapy Product by Application (2018-2033)
Figure 60. Global Cellular and Gene Therapy Product Price (US$/Unit) by Application (2018-2033)
Figure 61. Cellular and Gene Therapy Product Value Chain
Figure 62. Cellular and Gene Therapy Product Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed